Today the Supreme Court agreed to review three cases, none of which were Sherley v Sebelius.

What a great day!

For those curious, Certiorari Granted (subheading on Supreme Court announcement) means the Court has granted review of these cases.

This is wonderful news for patients, the stem cell field, and probably biotech Advanced Cell Technology (ACT; symbol ACTC). It’s stock was up Friday sharply and is already zooming again today.

As much as adult stem cells and iPS cells are great tools for regenerative medicine and cellular therapy, realistically we need embryonic stem cell research too for many reasons. Adult stem cells and iPS cells are not panaceas.